Global and Japan Zonisamide Market Insights, Forecast to 2026

Publication ID:

QYR11200985

Publication Date:

November 23, 2020

Pages:

143

Publisher:

QYR

Region:

Global [1]

$3,900.00

Description:

Zonisamide market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Zonisamide market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Zonisamide market is segmented into
25mg
50mg
100mg

Segment by Application, the Zonisamide market is segmented into
Adult
Pediatric
Geriatric

Regional and Country-level Analysis
The Zonisamide market is analysed and market size information is provided by regions (countries).
The key regions covered in the Zonisamide market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Zonisamide Market Share Analysis
Zonisamide market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Zonisamide business, the date to enter into the Zonisamide market, Zonisamide product introduction, recent developments, etc.
The major vendors covered:
Concordia
Eisai
Zydus Pharmaceuticals
Sun Pharma
Wockhardt
Mylan
APOTEX
Teva
Glenmark
Bluepharma
Invagen Pharmaceuticals
Intas Pharmaceuticals

Table Of Contents:

1 Study Coverage
1.1 Zonisamide Product Introduction
1.2 Market Segments
1.3 Key Zonisamide Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Zonisamide Market Size Growth Rate by Type
1.4.2 25mg
1.4.3 50mg
1.4.4 100mg
1.5 Market by Application
1.5.1 Global Zonisamide Market Size Growth Rate by Application
1.5.2 Adult
1.5.3 Pediatric
1.5.4 Geriatric
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Zonisamide Market Size, Estimates and Forecasts
2.1.1 Global Zonisamide Revenue 2015-2026
2.1.2 Global Zonisamide Sales 2015-2026
2.2 Global Zonisamide, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Zonisamide Historical Market Size by Region (2015-2020)
2.3.1 Global Zonisamide Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Zonisamide Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Zonisamide Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Zonisamide Sales Forecast by Region (2021-2026)
2.4.2 Global Zonisamide Revenue Forecast by Region (2021-2026)

3 Global Zonisamide Competitor Landscape by Players
3.1 Global Top Zonisamide Sales by Manufacturers
3.1.1 Global Zonisamide Sales by Manufacturers (2015-2020)
3.1.2 Global Zonisamide Sales Market Share by Manufacturers (2015-2020)
3.2 Global Zonisamide Manufacturers by Revenue
3.2.1 Global Zonisamide Revenue by Manufacturers (2015-2020)
3.2.2 Global Zonisamide Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Zonisamide Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Zonisamide Revenue in 2019
3.2.5 Global Zonisamide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Zonisamide Price by Manufacturers
3.4 Global Zonisamide Manufacturing Base Distribution, Product Types
3.4.1 Zonisamide Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Zonisamide Product Type
3.4.3 Date of International Manufacturers Enter into Zonisamide Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Zonisamide Market Size by Type (2015-2020)
4.1.1 Global Zonisamide Sales by Type (2015-2020)
4.1.2 Global Zonisamide Revenue by Type (2015-2020)
4.1.3 Zonisamide Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Zonisamide Market Size Forecast by Type (2021-2026)
4.2.1 Global Zonisamide Sales Forecast by Type (2021-2026)
4.2.2 Global Zonisamide Revenue Forecast by Type (2021-2026)
4.2.3 Zonisamide Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Zonisamide Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Zonisamide Market Size by Application (2015-2020)
5.1.1 Global Zonisamide Sales by Application (2015-2020)
5.1.2 Global Zonisamide Revenue by Application (2015-2020)
5.1.3 Zonisamide Price by Application (2015-2020)
5.2 Zonisamide Market Size Forecast by Application (2021-2026)
5.2.1 Global Zonisamide Sales Forecast by Application (2021-2026)
5.2.2 Global Zonisamide Revenue Forecast by Application (2021-2026)
5.2.3 Global Zonisamide Price Forecast by Application (2021-2026)

6 Japan by Players, Type and Application
6.1 Japan Zonisamide Market Size YoY Growth 2015-2026
6.1.1 Japan Zonisamide Sales YoY Growth 2015-2026
6.1.2 Japan Zonisamide Revenue YoY Growth 2015-2026
6.1.3 Japan Zonisamide Market Share in Global Market 2015-2026
6.2 Japan Zonisamide Market Size by Players (International and Local Players)
6.2.1 Japan Top Zonisamide Players by Sales (2015-2020)
6.2.2 Japan Top Zonisamide Players by Revenue (2015-2020)
6.3 Japan Zonisamide Historic Market Review by Type (2015-2020)
6.3.1 Japan Zonisamide Sales Market Share by Type (2015-2020)
6.3.2 Japan Zonisamide Revenue Market Share by Type (2015-2020)
6.3.3 Japan Zonisamide Price by Type (2015-2020)
6.4 Japan Zonisamide Market Estimates and Forecasts by Type (2021-2026)
6.4.1 Japan Zonisamide Sales Forecast by Type (2021-2026)
6.4.2 Japan Zonisamide Revenue Forecast by Type (2021-2026)
6.4.3 Japan Zonisamide Price Forecast by Type (2021-2026)
6.5 Japan Zonisamide Historic Market Review by Application (2015-2020)
6.5.1 Japan Zonisamide Sales Market Share by Application (2015-2020)
6.5.2 Japan Zonisamide Revenue Market Share by Application (2015-2020)
6.5.3 Japan Zonisamide Price by Application (2015-2020)
6.6 Japan Zonisamide Market Estimates and Forecasts by Application (2021-2026)
6.6.1 Japan Zonisamide Sales Forecast by Application (2021-2026)
6.6.2 Japan Zonisamide Revenue Forecast by Application (2021-2026)
6.6.3 Japan Zonisamide Price Forecast by Application (2021-2026)

7 North America
7.1 North America Zonisamide Market Size YoY Growth 2015-2026
7.2 North America Zonisamide Market Facts & Figures by Country
7.2.1 North America Zonisamide Sales by Country (2015-2020)
7.2.2 North America Zonisamide Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada

8 Europe
8.1 Europe Zonisamide Market Size YoY Growth 2015-2026
8.2 Europe Zonisamide Market Facts & Figures by Country
8.2.1 Europe Zonisamide Sales by Country
8.2.2 Europe Zonisamide Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia

9 Asia Pacific
9.1 Asia Pacific Zonisamide Market Size YoY Growth 2015-2026
9.2 Asia Pacific Zonisamide Market Facts & Figures by Country
9.2.1 Asia Pacific Zonisamide Sales by Region (2015-2020)
9.2.2 Asia Pacific Zonisamide Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam

10 Latin America
10.1 Latin America Zonisamide Market Size YoY Growth 2015-2026
10.2 Latin America Zonisamide Market Facts & Figures by Country
10.2.1 Latin America Zonisamide Sales by Country
10.2.2 Latin America Zonisamide Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Zonisamide Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Zonisamide Market Facts & Figures by Country
11.2.1 Middle East and Africa Zonisamide Sales by Country
11.2.2 Middle East and Africa Zonisamide Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E

12 Company Profiles
12.1 Concordia
12.1.1 Concordia Corporation Information
12.1.2 Concordia Description and Business Overview
12.1.3 Concordia Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Concordia Zonisamide Products Offered
12.1.5 Concordia Recent Development
12.2 Eisai
12.2.1 Eisai Corporation Information
12.2.2 Eisai Description and Business Overview
12.2.3 Eisai Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Eisai Zonisamide Products Offered
12.2.5 Eisai Recent Development
12.3 Zydus Pharmaceuticals
12.3.1 Zydus Pharmaceuticals Corporation Information
12.3.2 Zydus Pharmaceuticals Description and Business Overview
12.3.3 Zydus Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Zydus Pharmaceuticals Zonisamide Products Offered
12.3.5 Zydus Pharmaceuticals Recent Development
12.4 Sun Pharma
12.4.1 Sun Pharma Corporation Information
12.4.2 Sun Pharma Description and Business Overview
12.4.3 Sun Pharma Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Sun Pharma Zonisamide Products Offered
12.4.5 Sun Pharma Recent Development
12.5 Wockhardt
12.5.1 Wockhardt Corporation Information
12.5.2 Wockhardt Description and Business Overview
12.5.3 Wockhardt Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Wockhardt Zonisamide Products Offered
12.5.5 Wockhardt Recent Development
12.6 Mylan
12.6.1 Mylan Corporation Information
12.6.2 Mylan Description and Business Overview
12.6.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Mylan Zonisamide Products Offered
12.6.5 Mylan Recent Development
12.7 APOTEX
12.7.1 APOTEX Corporation Information
12.7.2 APOTEX Description and Business Overview
12.7.3 APOTEX Sales, Revenue and Gross Margin (2015-2020)
12.7.4 APOTEX Zonisamide Products Offered
12.7.5 APOTEX Recent Development
12.8 Teva
12.8.1 Teva Corporation Information
12.8.2 Teva Description and Business Overview
12.8.3 Teva Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Teva Zonisamide Products Offered
12.8.5 Teva Recent Development
12.9 Glenmark
12.9.1 Glenmark Corporation Information
12.9.2 Glenmark Description and Business Overview
12.9.3 Glenmark Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Glenmark Zonisamide Products Offered
12.9.5 Glenmark Recent Development
12.10 Bluepharma
12.10.1 Bluepharma Corporation Information
12.10.2 Bluepharma Description and Business Overview
12.10.3 Bluepharma Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Bluepharma Zonisamide Products Offered
12.10.5 Bluepharma Recent Development
12.11 Concordia
12.11.1 Concordia Corporation Information
12.11.2 Concordia Description and Business Overview
12.11.3 Concordia Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Concordia Zonisamide Products Offered
12.11.5 Concordia Recent Development
12.12 Intas Pharmaceuticals
12.12.1 Intas Pharmaceuticals Corporation Information
12.12.2 Intas Pharmaceuticals Description and Business Overview
12.12.3 Intas Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Intas Pharmaceuticals Products Offered
12.12.5 Intas Pharmaceuticals Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Zonisamide Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Zonisamide Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

Companies Mentioned:

Concordia
Eisai
Zydus Pharmaceuticals
Sun Pharma
Wockhardt
Mylan
APOTEX
Teva
Glenmark
Bluepharma
Invagen Pharmaceuticals
Intas Pharmaceuticals

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.